Skip to main content
ImmuneCited

Garlic 관련 Upper Respiratory Tract Infections

B

A 12-week randomized controlled trial found the garlic group experienced 63% fewer colds, 70% shorter symptom duration, and significantly fewer viral-challenged days (111 vs 365) compared to placebo. While promising, human clinical trials remain limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dgarlic\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

A 12-week randomized controlled trial found the garlic group experienced 63% fewer colds, 70% shorter symptom duration, and significantly fewer viral-challenged days (111 vs 365) compared to placebo. While promising, human clinical trials remain limited.

Key Study Findings

Other n=80 3 weeks Double-blind
Investigation of the natural supplement IQP-AS-119 for the prevention of upper respiratory tract infections in …
Dose: 20.0% vs: placebo Outcome: None 효과: or 14 P=0.038

대상 집단: None

Other 17.3 weeks
Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Alzheimer's disease patients

Review
Treatment of the common cold in children and adults.
Dose: None vs: None Outcome: infection rate 효과: None None

대상 집단: None

Review
Chemoprevention of bladder cancer.
Dose: Various nutrients (selenium, vitamins, green tea) vs: None Outcome: Bladder cancer chemoprevention 효과: None None

대상 집단: Bladder cancer patients

Meta-Analysis
Unsafe and potentially safe herbal therapies.
Dose: None vs: None Outcome: lipid levels 효과: None None

대상 집단: hypertensive patients

Key Statistics

3

연구

300

참여자

Positive

B

등급

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

fresh:
2-5 g raw garlic/day
general:
600-1,200 mg aged garlic extract/day

상한량: No established UL; high doses may increase bleeding risk

연구에서 사용된 용량

용량 기간 효과 N
20.0% 3 weeks Mixed 80
None 17.3 weeks Positive --
None -- Mixed --
Various nutrients (selenium, vitamins, green tea) -- Positive --
None -- Mixed --

권장 복용 시간: With meals to reduce GI discomfort

Safety & Side Effects

보고된 부작용

  • Gastrointestinal discomfort (heartburn, gas, nausea)
  • Body and breath odor
  • Increased bleeding risk
  • Allergic reactions (contact dermatitis, rare)

알려진 상호작용

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • HIV protease inhibitors (saquinavir — may reduce drug levels)
  • CYP2E1 substrates (garlic may alter metabolism)
  • Isoniazid (may reduce drug absorption)

일일 최대 섭취 허용량: No established UL; high doses may increase bleeding risk

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Garlic help with Upper Respiratory Tract Infections?
Based on 3 studies with 300 participants, there is moderate evidence from clinical studies that Garlic may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Garlic should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 2-5 g raw garlic/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Garlic?
Reported side effects may include Gastrointestinal discomfort (heartburn, gas, nausea), Body and breath odor, Increased bleeding risk, Allergic reactions (contact dermatitis, rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Garlic and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Upper Respiratory Tract Infections

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.